FANCD2 / Fanconi anemia group D2 protein · Western blot design guide

Design a Western Blot for FANCD2

Real validated FANCD2 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-FANCD2 WB antibodies. Everything you need to plan the experiment before you commit precious samples.

Evidence assembled September 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for FANCD2: expected band ~164.1 kDa, hero antibody A00563, catalog values and labelled standard workflow; separate PMC comparisons on the guide
Printable FANCD2 Western blot protocol sheet — expected band ~164.1 kDa, antibody A00563, controls and PMC citations. Open the full FANCD2 WB guide →

FANCD2 Western Blot Experimental Design Guide

Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band ~164.1 kDa
Gel 8–10% (standard starting point)
Positive control ⓘ Testis (IHC candidate; verify WB) +4 more
Negative control ⓘ Adipose tissue (IHC candidate; verify WB)
Important caveats
Reasons your observed band may differ from the expected size.
PTM Phosphorylated + Ubl conjugation
Caveat Modification-state controls
Gene-set association MSigDB C7 membership
Isoform 4 isoform(s)
Section 1

Real Curated FANCD2 Western Blot Protocols

The A00563 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.

Recommended Western blot protocol parameters
Sample / lysatevarious cells (catalog A00563)
Gel %8–10% (standard starting point)
Load20–30 µg total protein per lane; optimize for abundance (standard starting point)
TransferWet/tank transfer; optimize duration (standard starting point)
Membrane0.45 µm PVDF (standard starting point)
Blocking5% milk or 5% BSA in TBST (standard starting point)
Primary antibodyA00563 · 1:500 (catalog A00563)
Primary incubationOvernight at 4 °C (standard starting point)
Secondary antibodySpecies-matched HRP conjugate at validated dilution (standard starting point)
Secondary incubation1 h at room temperature (standard starting point)
Wash3 × 5 min in TBST (standard starting point)
DetectionECL; bracket exposures to avoid saturation (standard starting point)
Section 2

What Is the Expected FANCD2 Western Blot Band Size?

FANCD2 has a predicted 164.1 kDa monomer; isoforms and homodimerization could affect patterns, but no empirical migration is supplied.

What am I looking at on my blot?
Band near 164.1 kDaConsistent with the predicted FANCD2 monomer; confirm identity with appropriate controls
Band near twice the monomer sizeCould reflect a homodimer if it survives electrophoresis; no inter-chain disulfide is listed
Several bands at different positionsCould reflect FANCD2 isoforms 1, 2, 3, and 4; distinct migration is unverified
Weak band in a cytoplasmic fractionFANCD2 is nuclear, so nuclear enrichment may improve detection
💡Expected FANCD2 appearanceUniProt predicts a 164.1 kDa FANCD2 monomer; no empirical band size is supplied, and the listed isoforms and homodimer do not establish additional blot positions without band-identity controls.
How each factor affects band size
Predicted monomer massPlaces full-length FANCD2 near 164.1 kDa by sequence
Isoform 1May differ in size from other named isoforms; its mass is not supplied
Isoform 2May differ in size from other named isoforms; its mass is not supplied
Isoforms 3 and 4May differ in size from other named isoforms; their masses are not supplied
HomodimerCould appear near twice the monomer size if the complex survives electrophoresis
Why is my band missing or off?
SituationLikely causeNext action
No band in lysateNuclear FANCD2 may be underrepresented in the sampled fractionCheck a nuclear extract and a nuclear fraction marker
Band higher than expectedA FANCD2 homodimer may persist, though its migration is unverifiedCompare denaturing conditions and confirm the band with FANCD2 depletion
Band lower than expectedAn alternative isoform or protein breakdown is possibleCompare antibodies targeting different regions and confirm with FANCD2 depletion
Multiple bandsFour named isoforms are listed, but their band positions are unknownCheck which bands decrease after FANCD2 depletion
Weak or no signalThe nuclear target may be poorly recoveredVerify nuclear extraction and sample loading
Fragments below expected sizeProtein breakdown during preparation is possiblePrepare fresh lysate with protease inhibitors and compare antibody epitopes

Sample controls for FANCD2 Western blot

🧪HPA-IHC candidate guidance (verify in WB): For positive controls for FANCD2 in Western blot, you can use testis lysate, as HPA reports high expression in testis.
Positive control: Testis (IHC candidate; verify WB)
Negative control: Adipose tissue (IHC candidate; verify WB)
Loading controls: Run GAPDH, β-actin, and a total-protein stain such as Ponceau alongside the samples.
⚠️Feasibility: HPA provides a not-detected tissue control, and FANCD2’s nuclear location may favor nuclear-enriched lysate for detection.

HPA tissue expression evidence for FANCD2

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Higher expression tissues · candidate positive controls from IHC

TissueCell typeLevelEvidenceSource
Testis pachytene spermatocytes High Protein (IHC) HPA →
Colon glandular cells Medium Protein (IHC) HPA →
Duodenum glandular cells Medium Protein (IHC) HPA →
Esophagus squamous epithelial cells Medium Protein (IHC) HPA →
Nasopharynx ciliated cells (cell body) Medium Protein (IHC) HPA →

Lower expression tissues · IHC evidence, not confirmed WB-negative controls

TissueCell typeLevelEvidenceSource
Adipose tissue adipocytes Not detected Protein (IHC) HPA →
Adrenal gland glandular cells Not detected Protein (IHC) HPA →
Breast adipocytes Not detected Protein (IHC) HPA →
Bronchus basal cells Not detected Protein (IHC) HPA →
Caudate glial cells Not detected Protein (IHC) HPA →
Section 3

Advanced FANCD2 Western Blot Tips

Deeper troubleshooting and optimisation questions for FANCD2, answered from its protein features.

How should FANCD2 band migration be interpreted?
Band shift · Use the separately labelled calculated mass and catalog-observed evidence above. A sequence annotation does not establish an observed migration shift. Verify target identity with orthogonal controls.
How could FANCD2 isoforms affect band interpretation?
Isoforms · Four isoforms are listed. Isoform 4 changes residues 232–241 and lacks 242–1451; isoform 3 changes 1229–1249 and lacks 1250–1451; isoform 1 replaces 1428–1451. These sequence differences could affect antibody recognition and band size. Check the antibody epitope before assigning a band to an isoform.
Which FANCD2 phosphorylation sites matter when interpreting bands?
PTM · UniProt lists phosphoserine at 8, 222, 592, 594, 717, 1257, 1401, 1404, 1412, 1423 and 1435, plus phosphothreonine at 1426. ATM is specified for serines 222, 1401 and 1404. These are UniProt coordinates; paper or antibody numbering may differ. The site annotations do not establish a visible band shift.
When should FANCD2 induction be assessed?
Induction · FANCD2 concentrates in nuclear foci during S phase and upon genotoxic stress, according to the supplied localization note. Compare matched cell cycle or stress conditions when assessing its localization or abundance. Nuclear foci indicate redistribution and do not, by themselves, establish increased total protein.
What transfer method to use for FANCD2 Western blot?
Transfer · FANCD2 has a predicted mass of 164.1 kDa. Choose a transfer protocol validated for proteins around that size and check transfer with a membrane stain. The supplied features do not specify a membrane, transfer apparatus or settings.
How should blocking be optimized?
Blocking · Standard workflow guidance: follow the A00563 datasheet where specified. Otherwise compare 5% milk or 5% BSA in TBST; for a phospho-specific assay start with BSA. Optimize background and specific signal with matched controls.
How should FANCD2 bands be quantified across conditions?
Quantitation · Use the same band definition and normalization approach across samples, and record cell cycle and genotoxic stress conditions. FANCD2 is nuclear and concentrates in foci during S phase and stress, so differences in sample preparation or nuclear recovery could affect measured signal. Verify that the quantified band corresponds to the intended isoform.
Why might FANCD2 migrate differently from its predicted mass?
Interpretation · The supplied sequence has a predicted mass of 164.1 kDa, but no observed band size is available. Phosphorylation and alternative isoforms are annotated; their presence alone does not establish a visible shift or explain a mass difference. Compare the observed band with a molecular weight marker and check which isoform the antibody recognizes.

Consider the annotated shorter isoforms 3 and 4, especially if the antibody recognizes a region they retain. Check the antibody epitope against their deleted regions. Phosphorylation is annotated, but does not alone identify an extra band or prove a mobility shift. No empirical FANCD2 band size was supplied.
Boster reagents

FANCD2 Western Blot Antibodies

Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.

Real WB data Western Blot analysis of various cells using FANCD2 Polyclonal Antibody diluted at 1:500 cells nucleus extracted by Minute TM Cytoplasmic and Nuclear Fractionation kit .
Anti-FANCD2 Antibody
Cat # A00563
Real WB data Western blot analysis of FANCD2 using anti-FANCD2 antibody (M00563). <br>
Electrophoresis was performed on a 5-20% SDS-PAGE gel at 70V (Stacking gel) / 90V (Resolving gel) for 2-3 hours. The sample well of each lane was loaded with 30 ug of sample under reducing conditions. <br>
Lane 1: human Hela whole cell lysates,<br>
Lane 2: human HepG2 whole cell lysates,<br>
Lane 3: human MCF-7 whole cell lysates.<br>
After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-FANCD2 antigen affinity purified monoclonal antibody (Catalog # M00563) at 1:1000 overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:500 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for FANCD2 at approximately 164kDa. The expected band size for FANCD2 is at 164 kDa.
Anti-FANCD2 Rabbit Monoclonal Antibody
Cat # M00563

A00563 and M00563 are anti-FANCD2 antibodies with WB images and listed human, mouse, and rat reactivity. M00563 shows an approximately 164 kDa band in human HeLa, HepG2, and MCF-7 lysates. The supplied captions do not document mouse or rat WB samples.

Which to pick: For human whole-cell lysates, M00563 has a documented 1:1000 WB example. A00563 shows WB on nuclear extracts from unspecified cells at 1:500. Both have WB images; choose based on your sample preparation and confirm performance in your own samples.

Source: BosterBio FANCD2 gene-info card — filtered to Western-blot-capable antibodies; each card shows that product's actual WB validation figure.